| The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled … C Chaccour, A Casellas, A Blanco-Di Matteo, I Pineda, ... EClinicalMedicine 32, 2021 | 231 | 2021 |
| Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital V Schöning, E Liakoni, C Baumgartner, AK Exadaktylos, WE Hautz, ... Journal of translational medicine 19, 1-11, 2021 | 55 | 2021 |
| Prediction of clinically relevant drug‐induced liver injury from structure using machine learning F Hammann, V Schöning, J Drewe Journal of Applied Toxicology 39 (3), 412-419, 2019 | 40 | 2019 |
| Modeling of SARS-CoV-2 treatment effects for informed drug repurposing C Kern, V Schöning, C Chaccour, F Hammann Frontiers in Pharmacology 12, 625678, 2021 | 16 | 2021 |
| How far have decision tree models come for data mining in drug discovery? V Schöning, F Hammann Expert opinion on drug discovery 13 (12), 1067-1069, 2018 | 16 | 2018 |
| The hepatotoxic potential of protein kinase inhibitors predicted with Random Forest and Artificial Neural Networks V Schöning, S Krähenbühl, J Drewe Toxicology letters 299, 145-148, 2018 | 13 | 2018 |
| Effectiveness of antiviral therapy in highly-transmissible variants of SARS-CoV-2: a modeling and simulation study V Schöning, C Kern, C Chaccour, F Hammann Frontiers in pharmacology 13, 816429, 2022 | 9 | 2022 |
| Editor’s Highlight: Identification of Any Structure-Specific Hepatotoxic Potential of Different Pyrrolizidine Alkaloids Using Random Forests and Artificial Neural Networks V Schöning, F Hammann, M Peinl, J Drewe Toxicological Sciences 160 (2), 361-370, 2017 | 9 | 2017 |
| A comparison of nine machine learning mutagenicity models and their application for predicting pyrrolizidine alkaloids C Helma, V Schöning, J Drewe, P Boss Frontiers in Pharmacology 12, 708050, 2021 | 7 | 2021 |
| Automatic identification of risk factors for SARS-CoV-2 positivity and severe clinical outcomes of COVID-19 using Data Mining and Natural Language Processing V Schöning, E Liakoni, J Drewe, F Hammann MedRxiv, 2021.03. 25.21254314, 2021 | 6 | 2021 |
| Spotlight on artificial intelligence in experimental pharmacology and drug discovery V Schöning, A Khurana, A Karolak Frontiers in Pharmacology 14, 1261141, 2023 | 3 | 2023 |
| Modeling Structure–Activity Relationship of AMPK Activation J Drewe, E Küsters, F Hammann, M Kreuter, P Boss, V Schöning Molecules 26 (21), 6508, 2021 | 3 | 2021 |
| In vitro hepatotoxicity of Petasites hybridus extract (Ze 339) depends on the concentration, the cytochrome activity of the cell system, and the species used K Forsch, V Schöning, GM Assmann, C Moser, B Siewert, V Butterweck, ... Phytotherapy research 34 (1), 184-192, 2020 | 2 | 2020 |
| Machine learning for the prediction of drug-induced toxicity V Schöning University_of_Basel, 2019 | 2 | 2019 |
| Development of an in vitro screening method of acute cytotoxicity of the pyrrolizidine alkaloid lasiocarpine in human and rodent hepatic cell lines by increasing susceptibility K Forsch, V Schöning, L Disch, B Siewert, M Unger, J Drewe Journal of ethnopharmacology 217, 134-139, 2018 | 1 | 2018 |
| Identification of structure-specific hepatotoxic potential of different pyrrolizidine alkaloids using Random Forest and artificial Neural Network V Schöning, F Hammann, J Drewe Toxicology Letters 280, S197, 2017 | 1 | 2017 |
| Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in Cimicifuga racemosa as Critical Mediators of AMPK Activation J Drewe, V Schöning, O Danton, A Schenk, G Boonen Pharmaceutics 16 (4), 511, 2024 | | 2024 |
| Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern V Schöning, E Liakoni, C Baumgartner, AK Exadaktylos, WE Hautz, ... Journal of translational medicine 20 (1), 427, 2022 | | 2022 |
| Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients V Schöning, F Hammann Pharmaceutics 14 (9), 1828, 2022 | | 2022 |
| Highly-transmissible Variants of SARS-CoV-2 May Be More Susceptible to Drug Therapy Than Wild Type Strains V Schöning, C Kern, C Chaccour, F Hammann | | 2021 |
Felix HammannUniversity Hospital BernPatvirtintas el. paštas med.unibe.ch
